Hepatitis B Virus Reactivation in a Chronic Lymphocytic Leukemia Patient Treated with Ibrutinib
Jung Hye Choi, Joon Young Hur, Young-Woong Won
Cancer Res Treat. 2023;55(2):704-705.     DOI: https://doi.org/10.4143/crt.2022.1524
Citations to this article as recorded by Crossref logo
HBV Reactivation in Patients Receiving Bruton Tyrosine Kinase Inhibitors (BTKIs): a Systematic Review and Meta-Analysis
Ahmed Azzam, Heba Khaled, Basem Osama Ashry, Sarah Mohamed Hussein, Manar Osama, Ameer Ahmed, Omar Yousef, Anees Hjazeen, Ahmed A. Allam, Gellan Alaa Mohamed Kamel
Current Infectious Disease Reports.2024;[Epub]     CrossRef
Hepatitis B Virus Reactivation with Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia: A Case Report and Literature Review
Arzu Altunçekiç Yıldırım, Celali Kurt, Burcu Ülküden, Yeliz Çetinkol
Viral Hepatitis Journal.2024; 30(1): 19.     CrossRef
Chlorambucil/ibrutinib
Reactions Weekly.2023; 1965(1): 147.     CrossRef